k.salinas
TL2 · Aalborg
Contributes reviews on supplier material. Based in Aalborg.
Joined 19 May 2025 · last posted 1d
79 posts, newest first. Showing up to 150.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #127 · Sourcing › Independent verification · 27 Jul 2026 · 28 likes What a supplier does when asked is itself information, and it is information that a chromatogram cannot provide. I would put this at better than even and not much better.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #67 · Sourcing › Regulatory · 24 Jul 2026 · 0 likes Where I part company with post #65, and it is a narrow parting. Two things can be true about compounding permissions at once: the mechanism is plausible and the…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #48 · Compounds › Repair & healing peptides · 23 Jul 2026 · 1 like Research use only, not approved for human use, and in this family that statement carries more weight than usual because the published human safety data is effectively…
-
What a certificate commits its issuer to Replied, post #81 · Analytics › COA interpretation · 22 Jul 2026 · 12 likes I had written a reply contradicting post #78 and deleted it. Here is what survived. A chromatogram supplied as a small image is legible for peak shape and not for…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #25 · Practice › Interactions · 9 Jul 2026 · 2 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Insurance and replacement policies, compared Replied, post #36 · Sourcing › Logistics · 22 Jun 2026 · 5 likes Fair, and the limits you put on it are the part I will remember.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #45 · Start Here › How to Ask · 16 Jun 2026 · 32 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #4 · Lounge › Off topic · 8 Jun 2026 · 10 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page. The part I am sure of is…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #78 · Sourcing › Vendor reports · 4 Jun 2026 · 0 likes The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and nobody minds. The number is defensible. The…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #25 · Practice › Storage & stability · 2 Jun 2026 · 6 likes Freezing a reconstituted peptide solution is not automatically protective. Freeze-thaw cycling is one of the harsher things you can do to a protein in solution, and a…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #5 · Sourcing › Red flags · 2 Jun 2026 · 24 likes The opening post and I disagree about the size of the effect, not about the direction. Inconsistency across documents: a certificate stating one purity, a website…
-
Alcohol: what is documented and what is folklore Replied, post #37 · Practice › Interactions · 1 Jun 2026 · 5 likes On post #35 — agreed on the reasoning, with one qualification. A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #23 · Practice › Reconstitution · 31 May 2026 · 22 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
-
I joined for one answer and stayed for a year — what changed my mind Started this topic · Start Here › Welcome · 29 May 2026 · 18 likes Posting this under the heading it deserves: I joined for one answer and stayed for a year — what changed my mind Everything below is what sits behind that. Question in…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #48 · Outcomes › Progress reports · 21 May 2026 · 20 likes Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not. If that reads as pedantic, it is, and it has…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #37 · Practice › Dosing & titration · 16 May 2026 · 17 likes Worth separating two things that post #35 runs together. The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #14 · Practice › Reconstitution · 13 May 2026 · 14 likes What I would want before treating Reconstituting a multi-strength kit as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #127 · Pharmacology › Pharmacokinetics · 2 May 2026 · 0 likes Post #123 and I disagree about the size of the effect, not about the direction. Washout after stopping takes roughly the same four to five half-lives as reaching steady…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #9 · Compounds › Semaglutide · 26 Apr 2026 · 26 likes Semaglutide and gastric emptying came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #35 · Sourcing › Red flags · 23 Apr 2026 · 24 likes Adding the measurement that post #34 says would settle it. Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #20 · Access › Pricing · 23 Apr 2026 · 11 likes Narrowing post #19, because the general version has more than one answer. Counterpoint on manufacturer assistance programmes, offered without confidence: the same…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #90 · Practice › Reconstitution · 14 Apr 2026 · 19 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #4 · Nutrition & Training › Protein & intake · 11 Apr 2026 · 19 likes Post #2 describes the usual case. This is about the unusual one. Distribution across the day appears to matter less than total for most outcomes, and it matters…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #33 · Clinical › Bloodwork · 7 Apr 2026 · 29 likes The arithmetic in post #31 is right; the assumption feeding it is the part to check. Liver enzyme changes during rapid weight loss are commonly reported and have…
-
A single out-of-range value on an otherwise normal panel Replied, post #31 · Clinical › Bloodwork · 5 Apr 2026 · 1 like Same experience here, different supplier, so it is at least not unique to one of them.
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #19 · Outcomes › Progress reports · 23 Mar 2026 · 3 likes Building on post #16 rather than restating it. I have been on both sides of the plateau argument in this category within eighteen months, which should tell you how…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #79 · Pharmacology › Pharmacokinetics · 22 Mar 2026 · 4 likes Post #75 put the caveat in the right place and I want to underline it. Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #67 · Practice › Interactions · 16 Mar 2026 · 2 likes Narrowing post #64, because the general version has more than one answer. The practical version of Metformin co-administration is three sentences long. The rigorous…
-
Oral versus injected administration claims for BPC-157 Replied, post #20 · Compounds › Repair & healing peptides · 15 Mar 2026 · 19 likes Worth separating two things that post #18 runs together. Worth stating the null on oral versus injected administration claims before we explain it: the observation may…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #52 · Research Methods › Statistics · 13 Mar 2026 · 0 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
-
Second pass at: What pooling buys you and what it destroys Replied, post #24 · Evidence › Meta-analyses · 5 Mar 2026 · 25 likes Practical experience of pooling buys, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Second pass at: Identical chromatograms across two different lots Replied, post #44 · Sourcing › Red flags · 5 Mar 2026 · 0 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not. Correct me on the…
-
The lowest dose that does anything: is that a real question? Replied, post #14 · Practice › Dosing & titration · 2 Mar 2026 · 0 likes Nothing here is medical advice, and a titration question is one of the few where a prescriber can genuinely answer in a minute what a thread will take a week to circle.…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #39 · Evidence › Trials · 17 Feb 2026 · 31 likes I disagree with the framing of Reading a supplementary appendix above, and I think it is a substantive disagreement rather than a terminological one. Setting out why,…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #47 · Analytics › Impurities & related substances · 16 Feb 2026 · 15 likes Aggregates may be a multiple of the monomer mass and may not elute at all under a standard method. What does not come off the column does not appear in the area…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #9 · Compounds › Tirzepatide · 6 Feb 2026 · 1 like Worth separating two things that post #5 runs together. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #8 · Start Here › Welcome · 1 Feb 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #39 · Compounds › Tirzepatide · 17 Jan 2026 · 3 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #36 · Clinical › Bloodwork · 14 Jan 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #12 · Practice › Side effects · 26 Dec 2025 · 0 likes Post #9 answers the question as asked. The question underneath it is different. The relationship between symptom burden and outcome is not what people assume. Feeling…
-
MHRA statements, read directly Replied, post #50 · Regional › UK & Ireland · 17 Dec 2025 · 24 likes If you are new and reading this thread for the answer to MHRA statements: the answer is conditional, the conditions are in the third reply, and the rest of the thread…
-
Airline travel with a temperature-sensitive injectable Replied, post #21 · Devices › Cold chain · 10 Dec 2025 · 0 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. Taking airline travel seriously for a moment rather than deflecting: the honest…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #10 · Compounds › Tirzepatide · 6 Dec 2025 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Second pass at: Programming during a large energy deficit Replied, post #76 · Nutrition & Training › Resistance training · 11 Nov 2025 · 0 likes Machine-based work is often better tolerated when energy is low and is not inferior for this purpose. If this contradicts something upthread, the upthread version may…
-
Documentation that appears only after payment Replied, post #65 · Sourcing › Red flags · 2 Nov 2025 · 0 likes I keep a log for documentation specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #38 · Start Here › How to Ask · 29 Oct 2025 · 11 likes I read post #34 twice before replying, because I had assumed the opposite. Context that matters: compound, how long in, current dose, relevant history. Context that…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #4 · Access › Pricing · 23 Oct 2025 · 17 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
-
Pooling trials with different estimands — what changed since Replied, post #34 · Evidence › Meta-analyses · 7 Oct 2025 · 6 likes Where the included trials share a sponsor and a protocol template, their errors correlate and pooling does not average them out. Same conclusion as the reply above,…
-
A preprint whose numbers changed substantially at publication Replied, post #78 · Evidence › Preprints · 4 Oct 2025 · 3 likes A preprint reporting a null result is more likely to stay a preprint, which biases the published literature and makes preprint servers more valuable rather than less.
-
Revisiting: German, French and Dutch differences, compared Replied, post #72 · Regional › European Union · 13 Sep 2025 · 2 likes Post #71 is right about the mechanism and I think understates the practical bit. The useful distinction on German is between what was measured and what was inferred…
-
A request that was declined, and the reasoning — a second dataset Replied, post #47 · Documentation › Wiki requests · 10 Aug 2025 · 0 likes A request is more likely to succeed with a proposed outline attached. "Somebody should write about X" rarely moves; a structure and two sections does. The confident…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #28 · Start Here › How to Ask · 22 Jul 2025 · 24 likes Post #27 describes the usual case. This is about the unusual one. Five questions in one post gets you one answer: the easiest one, usually not the one you needed most.…
-
Canadian access and provincial variation — one year on Replied, post #11 · Regional › North America · 20 Jul 2025 · 6 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. I changed my mind about Canadian access and provincial variation after someone here…
-
A field-by-field walk through a certificate of analysis Replied, post #84 · Analytics › COA interpretation · 16 Jul 2025 · 12 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #13 · Compounds › Retatrutide · 24 Jun 2025 · 3 likes Post #11 and I disagree about the size of the effect, not about the direction. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #44 · Pharmacology › Pharmacokinetics · 13 Jun 2025 · 9 likes Renal impairment changes clearance for some compounds in this class and not others, and the published data is compound-specific rather than class-wide. Two sources,…
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #15 · Nutrition & Training › Hydration & electrolytes · 20 May 2025 · 0 likes Commercial rehydration formulations are designed for a specific purpose and are not equivalent to a sports drink, whatever the marketing suggests.
-
Needle changes between doses on a reusable pen Replied, post #7 · Devices › Pens & autoinjectors · 7 May 2025 · 1 like This follows post #4 rather than contradicting it. Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays…
-
A promotion I argued against, and why I lost Replied, post #139 · Documentation › Doc review · 19 Mar 2025 · 22 likes I came in to disagree and I am leaving without a disagreement.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #120 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
Validating a method you did not develop — does this still hold? Replied, post #119 · Analytics › Method validation · 15 Mar 2025 · 13 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #13 · Practice › Interactions · 12 Mar 2025 · 5 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of…
-
Consistent declarations and why they matter more than clever ones Replied, post #118 · Sourcing › Logistics · 3 Mar 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #57 · Sourcing › Regulatory · 2 Mar 2025 · 0 likes This follows post #56 rather than contradicting it. The strongest argument against my own position on pharmaceutical compounding rules, stated as well as I can state…
-
A promotion I argued against, and why I lost Replied, post #94 · Documentation › Doc review · 12 Feb 2025 · 0 likes One more thing on promotion that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #36 · Clinical › Bloodwork · 29 Jan 2025 · 9 likes The most useful reply I ever got about Lipid changes during rapid weight was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #42 · Wellbeing › Mental health · 25 Jan 2025 · 3 likes On anxiety the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #35 · Compounds › Secretagogues & GH axis · 17 Jan 2025 · 32 likes Everything in post #33 holds. The case it does not cover is the one I have. The strongest argument against my own position on well-designed human trial, stated as well…
-
Reading a supplementary appendix and finding the interesting part Replied, post #67 · Evidence › Trials · 14 Jan 2025 · 6 likes Checked the reading a supplementary appendix claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #144 · Clinical › Prescriber conversations · 11 Jan 2025 · 27 likes Written summaries after an appointment are available in many systems and are worth asking for, because recollection of a consultation is unreliable.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #38 · Compounds › Other compounds · 12 Dec 2024 · 8 likes Genuine question rather than a rhetorical one: has anyone here actually observed Research-use-only status, as opposed to read about it? The thread is long and I cannot…
-
Fixed versus detachable needles: the trade-offs Replied, post #28 · Devices › Syringes & needles · 1 Dec 2024 · 14 likes Everything in post #24 holds. The case it does not cover is the one I have. The quoted dead-volume figures for common configurations vary between manufacturers and the…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #30 · Access › Insurance & coverage · 17 Nov 2024 · 23 likes A note on scope: what I am saying about Step therapy requirements applies to the case in the first post and I would not extend it further without checking.
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #8 · Sourcing › Regulatory · 17 Oct 2024 · 21 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #46 · Compounds › Other compounds · 12 Oct 2024 · 28 likes Melanotan II is a non-selective melanocortin agonist, which is why its effects are not confined to pigmentation. The non-selectivity is the mechanism and not a side…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #5 · Practice › Reconstitution · 6 Oct 2024 · 1 like Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Why a preprint's supplementary material is often the best part Replied, post #38 · Evidence › Preprints · 26 Sep 2024 · 0 likes Where I part company with post #34, and it is a narrow parting. A preprint with the data and code attached is frequently more checkable than a published paper without…
-
Correlation in a self-tracked dataset: what it can support Replied, post #79 · Research Methods › Statistics · 23 Aug 2024 · 4 likes Careful with the language on correlation. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Guidelines revision: what changed and why Replied, post #37 · Meta › Announcements · 26 Jul 2024 · 2 likes Confirming post #35 from a second method, which matters more than confirming it from a second person. The most useful thing anyone has posted about guidelines revision…